385 related articles for article (PubMed ID: 18725250)
1. Cellular functions of cardiolipin in yeast.
Joshi AS; Zhou J; Gohil VM; Chen S; Greenberg ML
Biochim Biophys Acta; 2009 Jan; 1793(1):212-8. PubMed ID: 18725250
[TBL] [Abstract][Full Text] [Related]
2. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
Ye C; Shen Z; Greenberg ML
J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome.
Ye C; Lou W; Li Y; Chatzispyrou IA; Hüttemann M; Lee I; Houtkooper RH; Vaz FM; Chen S; Greenberg ML
J Biol Chem; 2014 Feb; 289(6):3114-25. PubMed ID: 24318983
[TBL] [Abstract][Full Text] [Related]
4. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
[TBL] [Abstract][Full Text] [Related]
5. Cardiolipin function in the yeast S. cerevisiae and the lessons learned for Barth syndrome.
Ji J; Greenberg ML
J Inherit Metab Dis; 2022 Jan; 45(1):60-71. PubMed ID: 34626131
[TBL] [Abstract][Full Text] [Related]
6. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
[TBL] [Abstract][Full Text] [Related]
7. Cardiolipin deficiency leads to the destabilization of mitochondrial magnesium channel MRS2 in Barth syndrome.
Joshi A; Gohil VM
Hum Mol Genet; 2023 Dec; 32(24):3353-3360. PubMed ID: 37721533
[TBL] [Abstract][Full Text] [Related]
8. Cardiolipin-deficient cells have decreased levels of the iron-sulfur biogenesis protein frataxin.
Li Y; Lou W; Grevel A; Böttinger L; Liang Z; Ji J; Patil VA; Liu J; Ye C; Hüttemann M; Becker T; Greenberg ML
J Biol Chem; 2020 Aug; 295(33):11928-11937. PubMed ID: 32636300
[TBL] [Abstract][Full Text] [Related]
9. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
[TBL] [Abstract][Full Text] [Related]
10. Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae Tafazzin.
Abe M; Hasegawa Y; Oku M; Sawada Y; Tanaka E; Sakai Y; Miyoshi H
J Biol Chem; 2016 Jul; 291(30):15491-502. PubMed ID: 27268057
[TBL] [Abstract][Full Text] [Related]
11. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
[TBL] [Abstract][Full Text] [Related]
12. Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins.
Duncan AL
Biochem Soc Trans; 2020 Jun; 48(3):993-1004. PubMed ID: 32453413
[TBL] [Abstract][Full Text] [Related]
13. Blocking phosphatidylglycerol degradation in yeast defective in cardiolipin remodeling results in a new model of the Barth syndrome cellular phenotype.
Káňovičová P; Čermáková P; Kubalová D; Bábelová L; Veselá P; Valachovič M; Zahumenský J; Horváth A; Malínský J; Balážová M
J Biol Chem; 2022 Jan; 298(1):101462. PubMed ID: 34864056
[TBL] [Abstract][Full Text] [Related]
14. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of branched-chain amino acid aminotransferases rescues the growth defects of cells lacking the Barth syndrome-related gene TAZ1.
Antunes D; Chowdhury A; Aich A; Saladi S; Harpaz N; Stahl M; Schuldiner M; Herrmann JM; Rehling P; Rapaport D
J Mol Med (Berl); 2019 Feb; 97(2):269-279. PubMed ID: 30604168
[TBL] [Abstract][Full Text] [Related]
16. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
[TBL] [Abstract][Full Text] [Related]
17. The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome.
Claypool SM; Boontheung P; McCaffery JM; Loo JA; Koehler CM
Mol Biol Cell; 2008 Dec; 19(12):5143-55. PubMed ID: 18799610
[TBL] [Abstract][Full Text] [Related]
18. Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
Ikon N; Ryan RO
Lipids; 2017 Feb; 52(2):99-108. PubMed ID: 28070695
[TBL] [Abstract][Full Text] [Related]
19. Loss of cardiolipin leads to perturbation of mitochondrial and cellular iron homeostasis.
Patil VA; Fox JL; Gohil VM; Winge DR; Greenberg ML
J Biol Chem; 2013 Jan; 288(3):1696-705. PubMed ID: 23192348
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.
Russo S; De Rasmo D; Signorile A; Corcelli A; Lobasso S
Sci Rep; 2022 Nov; 12(1):19847. PubMed ID: 36400945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
